SSA
CNST

Schonfeld Strategic Advisors’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Schonfeld Strategic Advisors’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-45,238
Closed -$917K – 2012
2020
Q3 		$917K Buy
45,238
+15,653
+53% +$382K 0.02% 723
2020
Q2 		$889K Buy
29,585
+9,181
+45% +$331K 0.02% 628
2020
Q1 		$641K Sell
20,404
-60,896
-75% -$2.12M 0.04% 500
2019
Q4 		$3.83M Buy
+81,300
New +$2.35M 0.09% 236
2018
Q4 		– Sell
-33,500
Closed -$225K – 1295
2018
Q3 		$225K Buy
+33,500
New +$319K 0.01% 747

Other funds holding CNST

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PM
Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Schonfeld Strategic Advisors's CNST Position: Q4 2020 in Review

Schonfeld Strategic Advisors sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q4 2020, closing a stake of 45,238 shares — an estimated $917K sold.

Schonfeld Strategic Advisors first reported a position in CNST in Q3 2018 and held it in 5 quarters. The position peaked at $3.83M in Q4 2019. 134 funds tracked by Wall St. Rank hold CNST as of Q4 2020.

  • Schonfeld Strategic Advisors reported no remaining Constellation Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 45,238 Constellation Pharmaceuticals, Inc. shares in Q4 2020, an estimated $917K.
  • Schonfeld Strategic Advisors first reported a position in Constellation Pharmaceuticals, Inc. in Q3 2018 and held it in 5 quarters.
  • Schonfeld Strategic Advisors's Constellation Pharmaceuticals, Inc. position peaked at $3.83M in Q4 2019.
  • 134 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q4 2020.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.